🇺🇸 FDA
Patent

US 11814394

Exatecan derivatives, linker-payloads, and conjugates and thereof

granted A61KA61K47/60A61K47/66

Quick answer

US patent 11814394 (Exatecan derivatives, linker-payloads, and conjugates and thereof) held by GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD.
Grant date
Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K47/60, A61K47/66, A61K47/68037, A61K47/6849